Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Key Information
Due Date: September 25, 2026
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This could include cancers originating from the same organ system, such as gastrointestinal or head and neck cancers, among others. The focus of the research could also extend to groups of cancers sharing a common biological mechanism that promotes cancer development and progression in different organ systems. For instance, a SPORE-supported project might focus on cancers caused by the same infectious agent or those triggered and maintained by dysregulation of a common signaling pathway. The grant also accommodates projects focusing on overarching themes like pediatric cancers or cancer health disparities.
All research supported through this program should be translational, meaning that it applies scientific research to enhance human health and well-being. The methodological approaches may involve cellular, molecular, structural, biochemical, and/or genetic experimental methods, all anchored in human biology. Crucially, all projects funded under this program should work towards reaching a specific goal with human application within the lifespan of the grant.
Key Dates
Open Date: September 22, 2023
Application Due Date: September 25, 2026
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses